Osborne Clarke advises Heartbeat Medical on investment from Holtzbrinck

Written on 22 December 2017


International legal practice Osborne Clarke has advised healthtech start-up Heartbeat Medical on a seed investment of €3 million Euro from Holtzbrinck Ventures.

The company has created a software that evaluates the success of medical treatment, by reviewing feedback from patients on their quality of life. Berlin Charité and the private hospital groups Sana and Helios already use the technology.

With the financing, Heartbeat Medical will further improve data analysis and give clients better access to information.

An Osborne Clarke team including Nicolas Gabrysch (Corporate) and Konstantin Ewald (IT) has advised Heartbeat Medical on this investment.

Connect with one of our experts